AVY
75
3
SNA
55
2
AVGO
40
-14
EFX
66
11
TGT
45
3
AMGN
57
11
BLK
69
3
ABBV
70
2
CNX
52
15
HD
50
-7
AES
54
3
PEG
46
5
JWN
55
2
ECL
70
-12
HPE
44
-2
CMS
65
5
JBHT
42
4
ADBE
60
-4
MDT
42
-2
BXP
46
4
AVY
75
3
SNA
55
2
AVGO
40
-14
EFX
66
11
TGT
45
3
AMGN
57
11
BLK
69
3
ABBV
70
2
CNX
52
15
HD
50
-7
AES
54
3
PEG
46
5
JWN
55
2
ECL
70
-12
HPE
44
-2
CMS
65
5
JBHT
42
4
ADBE
60
-4
MDT
42
-2
BXP
46
4
Financhill
Back

MYT Netherlands Parent BV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
50

MYTE
MYT Netherlands Parent BV

Last Price:
5.08
Seasonality Move:
3.26%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
50
MYT Netherlands Parent BV (MYTE) is a Sell

Is MYT Netherlands Parent BV a Buy, Sell or Hold?

  • The current MYT Netherlands Parent BV [MYTE] share price is $4.93. The Score for MYTE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MYTE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MYTE Stock Price Chart

What is MYT Netherlands Parent BV's stock price today?

  • The MYT Netherlands Parent BV share price today is $4.93
    The current trend is relatively stagnant and MYTE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

MYTE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 46.71 Sell
Chaikin Money Flow: 87413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.92 - 5.64) Sell
Bollinger Bands (100): (3.1 - 4.94) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

MYTE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.03 Sell
20-day SMA: 5.34 Sell
50-day SMA: 4.75 Buy
200-day SMA: 3.62 Buy
8-day EMA: 5.04 Sell
20-day EMA: 5.14 Sell
50-day EMA: 4.79 Buy
200-day EMA: 4.3 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

MYT Netherlands Parent BV Earnings Growth & MYTE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.08 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

MYT Netherlands Parent BV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):